Reports for RANBAXY PHARMACEUTICALS CANADA INC.

Company Name

RANBAXY PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

83

Actual shortage: 4 (5%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 79 (95%)

Discontinuation Reports

33

To be discontinued: 0 (0%)
Discontinued: 33 (100%)
Reversed: 0 (0%)

Late reports

53 (46%)

Overdue reports

4 (100%)

Showing 121 to 83 of 83

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAN-NABILONE 1MG CAPSULE Discontinued 2017-07-21 2017-07-21 16605
RAN-NABILONE 0.25MG CAPSULE Discontinued 2018-02-02 2018-02-03 38216
RAN-NABILONE 0.5MG CAPSULE Discontinued 2018-02-02 2018-02-03 38219
RAN-NABILONE 1MG CAPSULE Discontinued 2018-02-02 2018-02-03 38224
RAN-NABILONE 1MG CAPSULE Discontinued 2018-05-31 2018-06-01 50986
RAN-NABILONE 0.25MG CAPSULE Discontinued 2018-05-31 2018-06-01 50989
RAN-NABILONE 0.5MG CAPSULE Discontinued 2018-05-31 2018-06-01 50992
RAN-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-08-09 2019-08-10 91278
RAN-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-08-09 2019-08-10 91281
RAN-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-02-02 2020-02-02 105096
RAN-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-03-07 2020-03-07 108130
RAN-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Discontinued 2017-07-21 2017-07-21 16588
RAN-TADALAFIL 2.5MG TABLET Discontinued 2019-11-26 2019-11-26 99760

Showing 21 to 33 of 33